Research handbook on intellectual property and the life sciences / edited by Duncan Matthews, Herbert Zech.

Format:

Book

Contributor:

Matthews, Duncan, editor.

Zech, Herbert, editor.

Series:

Research Handbooks in Intellectual Property

Language:

English

Subjects (All):

Biotechnology industries--Law and legislation.

Biotechnology industries.

Intellectual property.

Life sciences.

Physical Description:

1 online resource (528 pages) : illustrations.

Place of Publication:

Cheltenham, United Kingdom : Edward Elgar Publishing, 2017.

Summary:

Intellectual property (IP) is a key component of the life sciences, one of the most dynamic and innovative fields of technology today. At the same time, the relationship between IP and the life sciences raises new public policy dilemmas. The Research Handbook on Intellectual Property and the Life Sciences comprises contributions by leading experts from academia and industry to provide in-depth analyses of key topics including pharmaceuticals, diagnostics and genes, plant innovations, stem cells, the role of competition law and access to medicines. The Research Handbook focuses on the relationship between IP and the life sciences in Europe and the United States, complemented by country-specific case studies on Australia, Brazil, China, India, Japan, Kenya, South Africa and Thailand to provide a truly international perspective.

Contents:

PART I: MEDICINE AND PHARMACEUTICALS

1. Patenting biosimilars

2. Patenting diagnostics

3. Patenting human genes in Europe – and how it compares to the US and Australia

4. Patenting human genes in the United States

5. An exorbitant monopoly: the High Court of Australia, Myriad Genetics, and gene patents

6. Exclusivity for biologics

PART II: AGRICULTURAL SECTOR (CROP SCIENCES)

7. Protection of plant innovations

8. Patenting non-transgenic plants in the EU

9. Non-obvious plants

10. Transgenic plants

11. Convention on Biological Diversity and regulatory law as plant protection

12. Patents on native traits: what scope of protection?

PART III: RESEARCH AND DEVELOPMENT

13. The European Union’s IP policy and funding of stem cell research

14. Stem cell patents in the United States

15. Early stage patenting, the US Bayh-Dole Act and the anti-commons hypothesis

16. IP in research and development agreements

17. Patent pools and clearinghouses in the life sciences: back to the future

PART IV: COUNTRY CASE STUDIES IN IP AND THE LIFE SCIENCES

18. Understanding the Brazilian patent reform

19. IP protection in the life sciences in China

20. Diverse harmonization: Indian example

21. Life science research and patents in Japan: a comparative study of life science invention patentability between the Japanese and US Patent Acts

22. Intellectual property and the life sciences in Kenya: enforcement and access to medicines

23. IP and life sciences: a case study of South Africa

24. Thailand’s compulsory licenses and the increase of investment arbitration

PART V: BOUNDARIES OF IP AND THELIFE SCIENCES

25. Parallel imports within the European Union

26. Pay for delay agreements

27. Abusive filing of IP rights.

Notes:

Includes index.

Description based on print version record.

ISBN:

1-78347-945-0